Nontuberculous Mycobacterium infection complicated with Haemophagocytic syndrome: a case report and literature review

Table 1 Laboratory results of our case

	First visit	First day after admission	1 week after admission	6-month follow-up
WBC (*10⁹/L)	4.36	2.28	1.02	3.45
NEUT (*10⁹/L)	3.66	1.77	0.71	2.87
HGB (g/L)	91	87	59	112
PLT (*10⁹/L)	109	71	51	141
ALT (U/L)		192		7
AST (U/L)		139		11
LDH (U/L)		554
Cr (μmol/L)		89		69
ESR (mm/h)		> 140
hsCRP (mg/L)		174		7.9
Triglyceride (mmol/L)		2.62
Fibrinogen (g/L)		3.5
Fer (ng/ml)		4090
B cell (/μl)		7		56
T cell (/μl)		233		459
NK cell (/μl)		6		89
Other	CMV-DNA, EBV-DNA, CMV-IgM, CMV-pp65, HIV antibody, T.SPOT-TB(−) ANA, ANCA, anti-RNP, anti-Sm, anti-SSA, anti-SSB, anti-rRNP, anti-Scl-70, anti-Jo-1, anti-PM-Scl, anti-dsDNA, anti-PCNA, ACA, AMA-M2, anti-histone antibodies, anti-CCP, ACL, anti-β2GP1, LAC, Coombs(−)

WBC, white blood cells; NEUT, neutrophils; HGB, haemoglobin; PLT, platelets; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactate dehydrogenase; Cr, creatinine; ESR, erythrocyte sedimentation rate; hsCRP, high-sensitivity C-reactive protein; Fer, ferritin; SF, serum ferritin; ANA, antinuclear antibody; ANCA, antineutrophil cytoplasmic antibodies; T.SPOT-TB, interferon-gamma release assay T.SPOT-TB; anti-RNP, anti-ribonucleoprotein antibodies; anti-Sm, anti-Smith antibody; anti-SSA, anti-Sjögren syndrome A antibody; anti-SSB, anti-Sjögren syndrome B antibody; anti-rRNP, anti-ribosomal RNP antibodies; anti-Scl-70, anti-Scl-70 antibody; anti-dsDNA, anti-double-stranded-DNA antibody; anti-Jo-1, anti-Jo-1 antibody; anti-PM-Scl, anti-exosome antibodies; anti-PCNA, anti-proliferating-cell-nuclear-antigen antibody; ACA, anticentromere antibody; AMA-M2, antimitochondrial antibody M2 subtype; CCP, cyclic citrullinated peptide; ACL, anti-cardiolipid antibody; β2GP1, β2-glycoprotein I; LAC, lupus anti-coagulant

ISSN: 1471-2334